NasdaqGM:CRMDPharmaceuticals
Is CorMedix (CRMD) A Potential Opportunity After Recent Share Price Volatility?
If you are wondering whether CorMedix at around US$7.27 is priced as a bargain or a trap, you are not alone. That is exactly what this valuation focused rundown aims to unpack.
The stock has been volatile recently, with a 7.2% gain over the last 7 days, a 42.0% decline over 30 days, and year to date and 1 year returns of 40.2% and 41.5% declines. The 3 year return sits at 68.7% and the 5 year return at a 16.9% decline.
Recent trading moves have put CorMedix back on the radar for investors...